| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |